$0.980
-0.020 (-2.02%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de HIT por análisis de gráficos similares
Alphio's HIT stock price prediction model matches the current Health In Tech Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.99 (+0.57%). The 1-week path is $0.99 (+1.12%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Health In Tech Inc?
Health In Tech, Inc. is currently not a good buy due to its declining revenue and negative earnings, despite a potential upside indicated by analyst targets. The current price is $0.98, with a forward P/E of 136.99, suggesting high expectations for future earnings. However, the company has reported a significant year-to-date decline of 44% and a one-year change of -65.97%, indicating ongoing financial struggles. The main risk is the recent revenue decline of 13.5% year-over-year, which raises concerns about its short-term performance.
HIT cerró en $0.98 el Friday, tras bajar -2.02%
Health In Tech Inc (HIT) last closed at $0.98, losing -2.02%. These facts feed the 1-day and 1-week HIT price prediction above.
Factores de la previsión
Los factores de la previsión de Health In Tech Inc (HIT) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de HIT, ordenadas por similitud.
Análisis de estacionalidad de HIT
Historically the probability of a positive August return for HIT is 0.00%. February offers the highest probability of a positive month at 47.37%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.